Consultant Surgical Oncology
Best Cancer Hospital in Thane, Mumbai | Oncology Center
The Department of Medical Oncology is an integral part of GHC Hospitals. The overall mission and goal of Department is to deliver advanced Oncology care in a Compassionate way to all our patients, and to provide world class treatment. Our endeavor will be to achieve excellence in basic research, and cancer treatment through multidisciplinary collaboration with surgical and Radiation Oncology specialists. Evidence based Oncology will be focus of attention. We are well equipped for latest diagnostics which include CT scan, MRI, flowcytometry, immunohistochemistry and molecular diagnostics as well. The treatment of cancer patients shall be individualized according to the stage, clinical profile and performance status of the patient. The modern oncological therapies such as immunotherapy, anti-angiogenesis targeted therapies and Bone Marrow Transplant shall be incorporated into treatment algorithms.
The reality of the day is to provide personalized cancer treatments to cancer patients by driving assessment of risk stratification based on DNA microarray. We wish to provide basic Oncology services immediately and gradually through our network we will be able to provide Bone marrow transplant facilities to our patient at reasonable cost.
About the Medical Oncology Department at GHC Hospitals, Thane and Mumbai
Medical oncology is the branch of medicine that deals with the diagnosis and non-surgical treatment of cancer. A medical oncologist is trained to use chemotherapy, immunotherapy, targeted therapy, hormone therapy, and other systemic treatments to manage cancer at every stage, from newly diagnosed cases to complex, advanced-stage disease.
GHC Hospitals is one of the best cancer hospitals in Mumbai and Thane, serving patients from Mumbra, Kausa, Kalwa, Diva, Thane, and Navi Mumbai. Our medical oncology department was built with a clear purpose: to bring expert cancer treatment in Mumbai and Thane to the patients who live here, so they do not have to cross the city or wait months in an overcrowded institution to receive the care they deserve.
As a complete oncology hospital in Mumbai , our department is fully equipped with a modern diagnostic unit, a dedicated chemotherapy daycare area, a bone marrow evaluation unit, and a clinical team that stays up to date with the latest developments in oncology. Every patient who comes to GHC Hospitals receives a treatment plan that is tailored to their specific cancer type, stage, genetic profile, and physical condition.
What Is Medical Oncology and How Is It Different from Surgical Oncology?
Many patients who search for a cancer specialist in Mumbai or a cancer hospital near Mumbra are unsure of the difference between a medical oncologist, a surgical oncologist, and a radiation oncologist. Understanding this helps patients know exactly what kind of specialist they need.
A medical oncologist uses systemic treatments such as chemotherapy, immunotherapy, targeted therapy, and hormone therapy. These treatments travel through the bloodstream and can reach cancer cells throughout the entire body, not just in one location. A surgical oncologist removes tumours through surgery. A radiation oncologist uses high-energy X-rays or other forms of radiation to destroy cancer cells. At GHC Hospitals, all three types of specialists work together as a multidisciplinary team, so patients receive a coordinated treatment plan rather than fragmented care from separate departments.
Cancers We Treat at Our Cancer Hospital in Mumbai and Thane
Our oncology hospitals in Mumbai manages a full range of cancers. Below is a detailed overview of the key cancer types treated by our medical oncology team at GHC Hospitals.
Breast cancer is the most common cancer in Indian women and accounts for a significant proportion of cases seen at any cancer hospital in Thane, Mumbai. It occurs when cells in the breast tissue grow abnormally and form a malignant tumour. Risk factors include a family history of breast cancer, BRCA1 or BRCA2 gene mutations, early onset of menstruation, late menopause, obesity, alcohol use, and hormone replacement therapy.
At GHC Hospitals, breast cancer treatment in Thane, Mumbai, is planned after a full evaluation including mammography, ultrasound, core needle biopsy, hormone receptor status (ER, PR), HER2 status, and where indicated, genetic testing. Based on the subtype, treatment may include neoadjuvant chemotherapy before surgery, adjuvant chemotherapy after surgery, hormone therapy for ER-positive cancers, HER2-targeted therapy for HER2-positive cancers (such as trastuzumab and pertuzumab), and CDK4/6 inhibitors for advanced hormone receptor-positive disease. Our medical oncologist coordinates closely with surgical and radiation oncology for complete management.
Blood cancers are malignancies that affect the blood, bone marrow, and lymphatic system. The three main types are leukaemia, lymphoma, and multiple myeloma. Leukaemia involves abnormal white blood cell production in the bone marrow. Lymphoma affects the lymphatic system and can be either Hodgkin or Non-Hodgkin type. Multiple myeloma is a cancer of the plasma cells in the bone marrow.
Blood cancer treatment in Mumbai at GHC Hospitals begins with accurate diagnosis using peripheral blood film, bone marrow biopsy, flowcytometry, cytogenetics, and molecular markers such as BCR-ABL, FLT3, and NPM1. Treatment protocols depend on the specific blood cancer type and may include CHOP, R-CHOP, or BFM regimens for lymphoma, TKI therapy for CML, induction and consolidation chemotherapy for AML and ALL, lenalidomide and bortezomib for myeloma, and evaluation for bone marrow transplant in Mumbai for eligible patients.
Lung cancer is the leading cause of cancer death worldwide and is strongly associated with tobacco smoking, though non-smokers can also develop it. There are two main types: non-small cell lung cancer (NSCLC), which accounts for about 85% of cases, and small cell lung cancer (SCLC). NSCLC is further divided into adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
At GHC Hospitals begins with CT chest, PET scan for staging, bronchoscopy, and molecular testing for EGFR, ALK, ROS1, KRAS, and PD-L1 expression. Patients with EGFR mutations receive targeted therapy with osimertinib or erlotinib. ALK-positive patients receive alectinib or crizotinib. PD-L1-high patients may receive immunotherapy with pembrolizumab as a first-line option. Advanced cases without a targetable mutation receive platinum-based chemotherapy combinations such as carboplatin with paclitaxel or pemetrexed.
Head and neck cancers include cancers of the oral cavity, oropharynx, hypopharynx, larynx, and salivary glands. They are among the most common cancers in India, closely linked to tobacco chewing, smoking, and betel nut use, which are widely prevalent in the Thane and Mumbra region. HPV infection is an increasing cause of oropharyngeal cancer in younger non-smoking patients.
Treatment of head and neck cancer at GHC Hospitals, as at any established cancer hospital in Mumbai, involves a multidisciplinary approach. Locally advanced cases receive concurrent chemoradiation with cisplatin as the standard protocol. Recurrent or metastatic head and neck cancer can be treated with platinum-fluorouracil-cetuximab (EXTREME regimen) or immunotherapy with pembrolizumab in PD-L1-positive cases.
Colorectal cancer, stomach cancer, oesophageal cancer, liver cancer, and pancreatic cancer are all managed in our medical oncology department at GHC Hospitals. Colorectal cancer treatment depends on microsatellite instability (MSI) status. MSI-high tumours respond well to immunotherapy with pembrolizumab. Standard chemotherapy regimens include FOLFOX and FOLFIRI, often combined with bevacizumab (an anti-angiogenesis agent) or cetuximab for KRAS wild-type tumours. Pancreatic and gastric cancers are treated with gemcitabine-based or FLOT regimens depending on the stage and intent.
Cervical cancer is caused primarily by persistent infection with high-risk strains of HPV, particularly HPV-16 and HPV-18. It remains one of the most preventable cancers when caught early through Pap smear and HPV screening. Locally advanced cervical cancer is treated with concurrent chemoradiation using weekly cisplatin. Metastatic cervical cancer is treated with platinum-based chemotherapy and bevacizumab. Ovarian cancer, depending on histology and BRCA status, may be treated with carboplatin-paclitaxel and PARP inhibitors such as olaparib for BRCA-mutated cases.
Differentiated thyroid cancers, including papillary and follicular thyroid cancers, are among the most treatable cancers with high survival rates when diagnosed at an early stage. After surgical removal, radioactive iodine therapy may be used. Anaplastic and medullary thyroid cancers require more aggressive management. Our cancer specialist in Mumbai and Thane coordinates with the surgical and endocrinology teams for complete thyroid cancer management at GHC Hospitals.
Childhood cancers are biologically different from adult cancers and require specialised treatment protocols. The most common childhood cancers include acute lymphoblastic leukaemia (ALL), brain tumours, Wilms tumour, neuroblastoma, and osteosarcoma. At GHC Hospitals, our medical oncology team works alongside our paediatrics department and uses international paediatric oncology protocols such as BFM and COG regimens. We provide a supportive, child-friendly environment for families going through one of the most difficult experiences possible, and keep parents fully informed and involved throughout treatment.
Complete Cancer Treatment Services at GHC Hospitals, Cancer Hospital in Mumbai and Thane
As a complete surgical oncology center in Thane, GHC Hospitals provides all treatment modalities under one roof. Patients do not need to travel between multiple hospitals for different parts of their care.
Chemotherapy uses cytotoxic drugs to kill rapidly dividing cancer cells throughout the body. It can be used as the primary treatment for certain cancers, before surgery (neoadjuvant), after surgery (adjuvant), or alongside radiation therapy (concurrent chemoradiation). Common chemotherapy drugs used at our chemotherapy hospital in Mumbai include cisplatin, carboplatin, paclitaxel, docetaxel, doxorubicin, cyclophosphamide, vincristine, etoposide, gemcitabine, capecitabine, 5-fluorouracil, oxaliplatin, and irinotecan, among others. The regimen is selected based on cancer type, stage, and the patient’s performance status and organ function.
GHC Hospitals operates a dedicated daycare chemotherapy unit where patients receive intravenous chemotherapy in a supervised setting and return home the same day. For patients who need inpatient chemotherapy due to the intensity of the regimen or complications, full inpatient oncology care is available. All chemotherapy is administered by trained oncology nurses under direct medical supervision. Patients are monitored for infusion reactions, blood counts, and organ function throughout their chemotherapy course.
Immunotherapy is one of the most important advances in cancer treatment over the past decade. It works by blocking proteins that prevent the immune system from recognising and attacking cancer cells. The most widely used immunotherapy agents are checkpoint inhibitors, which target PD-1, PD-L1, and CTLA-4 pathways.
Pembrolizumab and nivolumab are used for lung cancer, head and neck cancer, bladder cancer, melanoma, and other solid tumours that express PD-L1 or have high tumour mutational burden (TMB) or MSI-high status. Atezolizumab is used in bladder and lung cancers. Ipilimumab targets CTLA-4 and is often combined with nivolumab for melanoma and renal cell carcinoma. GHC Hospitals offers immunotherapy treatment in Thane, Mumbai, with careful patient selection based on biomarker testing, to ensure patients who receive immunotherapy have the best chance of responding to it.
Targeted therapy works by specifically attacking proteins or genes that are driving cancer growth. Unlike chemotherapy, which affects all rapidly dividing cells, targeted therapy is designed to act on specific molecular targets in cancer cells, causing fewer side effects in most cases.
Key targeted therapies used at GHC Hospitals include: trastuzumab and pertuzumab for HER2-positive breast cancer, osimertinib and erlotinib for EGFR-mutant lung cancer, alectinib and crizotinib for ALK-positive lung cancer, imatinib and dasatinib for CML and GIST, ribociclib and palbociclib (CDK4/6 inhibitors) for HR-positive breast cancer, bevacizumab for colorectal and ovarian cancer, rituximab for CD20-positive lymphomas, and olaparib for BRCA-mutated breast and ovarian cancers. The selection of targeted therapy depends on molecular testing results from biopsy tissue. Our cancer specialist in Thane reviews all molecular pathology before recommending targeted treatment.
Bone marrow transplant (BMT), also known as haematopoietic stem cell transplant (HSCT), is the treatment of choice for many haematological malignancies and some solid tumours. There are two main types of transplant: autologous transplant, where the patient’s own stem cells are collected before high-dose chemotherapy and then reinfused, and allogeneic transplant, where stem cells come from a matched donor.
Autologous BMT is commonly used for multiple myeloma, relapsed Hodgkin and non-Hodgkin lymphoma, and some cases of AML in remission. Allogeneic BMT is used for high-risk AML, ALL, CML, aplastic anaemia, and myelodysplastic syndrome. GHC Hospitals is building its bone marrow transplant in Mumbai programme to offer these services to patients in the Thane district at a transparent and reasonable cost, reducing the need for patients to travel to distant centres in Mumbai city for this life-saving treatment.
Radiation oncology uses high-energy beams, most commonly X-rays, to damage the DNA of cancer cells and prevent them from multiplying. Radiation can be used as the primary treatment for localised cancers such as early-stage head and neck cancer, prostate cancer, and cervical cancer. It is also used after surgery to eliminate any remaining cancer cells (adjuvant radiotherapy), or concurrently with chemotherapy (chemoradiation) for locally advanced cancers of the head and neck, cervix, oesophagus, and rectum.
GHC Hospitals works in close coordination with radiation oncology Mumbai specialists to plan and deliver radiotherapy as part of the overall treatment plan for patients who require it. Our multidisciplinary tumour board ensures that medical oncology and radiation oncology recommendations are made jointly, so patients receive an integrated plan and not two separate opinions that may conflict.
Tumours need to grow new blood vessels to sustain themselves, a process called angiogenesis. Anti-angiogenesis drugs block this process by targeting VEGF (Vascular Endothelial Growth Factor) or its receptors. Bevacizumab is the most widely used anti-angiogenesis agent and is part of standard protocols for colorectal cancer, non-squamous non-small cell lung cancer, ovarian cancer, and glioblastoma. Ramucirumab is used in gastric and lung cancer. At GHC Hospitals, anti-angiogenesis therapy is incorporated into treatment plans where there is clear evidence of clinical benefit.
Hormone therapy is used for cancers that are driven by the body’s own hormones, primarily breast cancer and prostate cancer. In hormone receptor-positive (ER/PR-positive) breast cancer, drugs such as tamoxifen (for pre-menopausal women) and aromatase inhibitors such as letrozole, anastrozole, and exemestane (for post-menopausal women) are used to block oestrogen’s ability to stimulate cancer cell growth. In prostate cancer, androgen deprivation therapy (ADT) using LHRH agonists or anti-androgens is the cornerstone of treatment for advanced disease. Hormone therapy at GHC Hospitals is managed as part of a comprehensive cancer treatment in Thane, Mumbai.
Palliative care is specialist medical care focused on providing relief from the symptoms, pain, and stress of cancer. It is appropriate at any stage of illness and can be provided alongside curative treatment, not just at the end of life. Good palliative care for cancer in Mumbai includes pain management using the WHO analgesic ladder, anti-emetic therapy for nausea and vomiting, management of cancer-related fatigue, breathlessness, and malnutrition, psychosocial support for patients and families, and coordination of end-of-life care for patients at advanced stages.
At GHC Hospitals, we believe that quality of life is as important as length of life. Our palliative care team works alongside the oncology team to ensure that patients at every stage of cancer are comfortable, informed, and supported. Palliative care is not giving up. It is making sure that whatever is happening medically, the person in front of us is living as well as they possibly can.
Receiving a cancer diagnosis is one of the most stressful experiences a person can face. It is natural to want confirmation before starting treatment, especially when surgery, chemotherapy, or other major interventions are recommended. GHC Hospitals offers second-opinion oncology in Thane, Mumbai, for patients who want an independent review of their diagnosis, staging, or proposed treatment plan.
Patients who come to us for a second opinion should bring their original biopsy report and histopathology slides, all imaging reports and films (CT, MRI, PET scan), any previous treatment records, and a list of current medications. Our medical oncologist will review all material and provide a detailed clinical opinion, which may confirm the original plan or suggest an alternative approach based on current evidence.
Advanced Cancer Diagnostics at GHC Hospitals, Oncology Hospital in Mumbra, Thane, Mumbai
Accurate and complete diagnosis is the foundation of effective cancer treatment. At GHC Hospitals, our oncology hospital in Mumbra uses the most current diagnostic tools to characterise every tumour before treatment begins.
- CT Scan: Used for initial staging to identify the size and extent of the primary tumour and assess lymph node and distant organ involvement.
- MRI: Particularly useful for brain tumours, spinal cord involvement, liver lesions, and soft tissue tumours where CT provides insufficient detail.
- PET-CT Scan: Combines metabolic activity with anatomical imaging to detect distant metastases and assess treatment response.
- Flowcytometry: Used to classify blood cancers by identifying the surface markers on abnormal cells in blood or bone marrow samples.
- Immunohistochemistry (IHC): A laboratory technique that uses antibodies to detect specific proteins in tumour tissue, critical for determining hormone receptor status, HER2 status, and lymphoma subtype.
- Molecular Diagnostics and NGS (Next Generation Sequencing): Identifies specific gene mutations in tumour tissue such as EGFR, ALK, KRAS, BRCA, and others that guide targeted therapy and immunotherapy decisions.
- DNA Microarray: Used for gene expression profiling and risk stratification to determine prognosis and guide personalised treatment decisions.
- Bone Marrow Biopsy and Aspiration: Used in blood cancers to assess the extent of marrow involvement and determine the subtype and risk categor
- Tumour Markers: Blood tests such as CEA (colorectal), CA-125 (ovarian), AFP (liver), PSA (prostate), beta-HCG (germ cell tumours), and LDH (lymphoma) for diagnosis and monitoring.
Multidisciplinary Tumour Board at GHC Hospitals, Cancer Hospital in Mumbra, Thane
The most important advancement in modern oncology is not any single drug or technology. It is the practice of multidisciplinary care, where specialists from different fields review each case together and agree on the best possible treatment plan before any treatment begins.
At GHC Hospitals, our tumour board brings together medical oncologists, surgical oncologists, radiation oncologists, radiologists, pathologists, and clinical nutritionists to discuss every complex cancer case. This means a patient with breast cancer does not receive a chemotherapy plan from the medical oncologist in isolation from the surgeon’s plan for surgery or the radiation oncologist’s plan for radiotherapy. All three plans are reviewed and integrated into a single, coordinated treatment approach.
This is the same standard of care used at Tata Memorial Hospital and other leading cancer hospitals in Mumbai, and it is available to patients at GHC Hospitals in Thane and Mumbra, without the waiting lists and the distance.
Why GHC Hospitals is Among the Best Cancer Hospitals in Mumbra, Thane, Mumbai
Best Oncologist in Mumbai Quality, Available in Thane
Patients from Mumbra, Thane, and Navi Mumbai who previously travelled to access the best oncologist in Mumbai can now receive equivalent expertise at GHC Hospitals without leaving the Thane district. Our oncologists follow the same international treatment guidelines used at ESMO, ASCO, and NCCN member institutions. They attend regular training and keep up with the latest developments in chemotherapy, immunotherapy, targeted therapy, and supportive oncology care.
Personalised Cancer Treatment, Not a Standard Protocol
At GHC Hospitals, cancer treatment in Mumbra, Thane is not a one-size-fits-all approach. Every patient receives an individualised treatment plan based on their cancer type, molecular subtype, stage, performance status, organ function, comorbidities, and personal circumstances. Two patients with breast cancer may receive entirely different treatment plans because their tumours behave differently at a molecular level. We use DNA microarray, NGS, and IHC to understand each tumour before choosing a treatment.
Affordable Cancer Treatment in Mumbra, Thane
Cost is one of the biggest barriers to cancer treatment in India. At GHC Hospitals, we are committed to making cancer treatment in Mumbra, Thane financially accessible. We accept most major private health insurance policies, government mediclaim, CGHS, and Ayushman Bharat PMJAY. For patients without insurance, we offer clear and transparent pricing and work to find the most cost-effective treatment options without compromising on quality or evidence-based care.
24/7 Oncology Support and Emergency Care
Cancer complications do not follow business hours. Neutropenic fever after chemotherapy, severe mucositis, acute pain, and other oncological emergencies need immediate attention. GHC Hospitals provides 24-hour emergency and inpatient support for oncology patients, with an on-call oncologist available for urgent situations at any hour. Our emergency team at our cancer hospital in Mumbai is trained to manage chemotherapy complications, acute pain crises, and other oncological emergencies promptly.
Convenient Location for Patients from Thane, Mumbra, and Navi Mumbai
GHC Hospitals is located on Thane Shil Road, Kausa, Thane, making it the most accessible cancer hospital in Thane for patients from Mumbra, Kausa, Kalwa, Diva, Airoli, and Navi Mumbai. Patients who previously had no choice but to travel to Parel or Mulund for cancer treatment can now access the same quality of care close to home. Less travel means more energy for recovery, more time with family, and less disruption to daily life during treatment.
Cancer Screening in Thane, Mumbai at GHC Hospitals
Cancer screening in Thane, Mumbai, is the process of looking for cancer before symptoms appear, when it is most treatable. GHC Hospitals recommends routine cancer screening for all individuals above the age of 40 and for younger individuals with known risk factors such as a family history of cancer, tobacco use, HPV infection, or BRCA gene mutations.
- Breast cancer screening: Annual mammography for women above 40, or earlier for those with a family history of breast cancer or known BRCA mutation.
- Cervical cancer screening: Pap smear every 3 years from age 21, or Pap smear plus HPV co-testing every 5 years from age 30.
- Colorectal cancer screening: Annual faecal occult blood test (FOBT) or colonoscopy every 10 years from age 45, or earlier for those with a family history.
- Oral cancer screening: Annual clinical examination, especially for tobacco chewers, betel nut users, and smokers.
- Prostate cancer screening: PSA blood test and digital rectal examination for men above 50, or above 40 for those at higher risk.
- Lung cancer screening: Annual low-dose CT scan for heavy smokers aged 50 to 80.
Call GHC Hospitals at +91 8104242551 to ask about our current cancer screening packages in Mumbra, Thane.
Cancer Warning Signs That Must Not Be Ignored
A large number of cancer deaths in India occur because patients visit a cancer hospital in Mumbai or Thane only when the disease is at an advanced stage. Many early warning signs are mistaken for minor illnesses. Knowing these signs and acting on them promptly can save lives.
- A new lump or swelling anywhere in the body, especially in the breast, neck, armpit, or groin
- Unexplained weight loss of more than 5 kg over a few weeks without a change in diet or exercise
- Persistent fatigue that does not improve with rest and has no obvious cause
- Unusual bleeding: blood in urine, stool, sputum, or abnormal vaginal bleeding
- A sore, ulcer, or wound anywhere on the body or in the mouth that does not heal within 3 weeks
- A change in bowel habits: persistent diarrhoea, constipation, or change in stool consistency lasting more than 4 weeks
- Persistent cough or hoarseness of voice lasting more than 3 weeks, especially in smokers
- Difficulty swallowing solid or liquid food, or a sensation of food getting stuck
- Skin changes: a new mole, or a mole that changes in size, shape, or colour; skin that becomes yellow or pale
- Persistent pain in any part of the body, such as bone pain, headaches, or abdominal pain without a clear diagnosis
None of these symptoms automatically mean cancer. Many have benign causes. But every one of them deserves a proper evaluation by a cancer specialist in Mumbai or Thane. If you have any of these symptoms, do not wait. Visit GHC Hospitals.
Meet Our Oncology Team Best Cancer Specialists in Thane, Mumbai, at GHC Hospitals
GHC Hospitals has a dedicated team of oncologists, surgical oncologists, a hemato-oncologist, and breast cancer specialists. Our cancer specialists in Thane, Mumbai, serve patients from Mumbra, Thane, Navi Mumbai, and the surrounding areas. Whether you need a medical oncologist in Thane for chemotherapy or immunotherapy, a surgical oncologist for cancer surgery, or a hemato-oncologist for blood cancer treatment in Mumbai, our team is here for you.
Consultant Surgical Oncology
Consultant Breast Oncoplastic & Endocrine Surgeon
Consultant Medical Oncologist
Consultant Surgical Oncologist
Consultant Oncology
Consultant Onco Surgeon
Consultant Surgical Oncologist
Cancer Hospital Near Me in Mumbai and Thane, Serving the Entire Region
GHC Hospitals is on Thane Shil Road, Kausa, Thane, making it the most accessible cancer hospital near Mumbra and the wider Thane and Navi Mumbai belt. Patients from the following areas come to GHC Hospitals for cancer treatment in Mumbai and Thane standards, without the travel burden of crossing into the city:
- Mumbra and Kausa: directly accessible, cancer hospital near Mumbra
- Kalwa and Diva
- Thane West and Thane East
- Airoli, Ghansoli, and Turbhe, Navi Mumbai: cancer hospital Navi Mumbai
- Vitthalwadi and Ulhasnagar
- Bhiwandi and Shahapur
- Dombivali and Ambernath
- Patients from central Mumbai and Mulund seeking affordable cancer treatment Mumbai with shorter travel
If you are looking for a cancer hospital near me in Mumbai or Thane, or a trusted oncology hospital in Mumbai standards right in the Thane district, GHC Hospitals is where you need to be.
Book Your Oncology Appointment at GHC Hospitals, Best Cancer Hospital in Thane
You do not need a referral to consult our cancer specialist in Mumbai and Thane at GHC Hospitals. If you have been recently diagnosed, if you are experiencing symptoms, or if you simply want a screening or a second opinion, our team is ready. Call us, walk in, or book online through our website.
We Provide the highest Level of comprehensive care & services to our patients.
📞08104242551
Frequently Asked Questions
What is the difference between medical oncology, surgical oncology, and radiation oncology?
Medical oncology focuses on treating cancer using systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and hormone therapy. Surgical oncology involves removing tumours and affected tissue through surgery. Radiation oncology uses high-energy radiation to destroy cancer cells. At GHC Hospitals, all three types of specialists collaborate in our multidisciplinary tumour board, so patients receive a coordinated treatment plan that incorporates all relevant treatment modalities.
Is GHC Hospitals one of the best cancer hospitals in Mumbai for Thane and Mumbra patients?
Yes. GHC Hospitals is one of the best cancer hospitals in Mumbai and Thane for patients from Mumbra, Kausa, Kalwa, Diva, Thane, and Navi Mumbai. We offer evidence-based medical oncology including chemotherapy, immunotherapy, targeted therapy, and coordination for bone marrow transplant in Mumbai, with a multidisciplinary team approach and advanced molecular diagnostics. Patients get Mumbai-level quality care without the long journey into the city.
What is chemotherapy and what side effects should I expect?
Chemotherapy uses drugs to destroy cancer cells or stop them from dividing. Side effects depend on which drugs are used and at what dose. Common side effects include nausea and vomiting (managed with anti-emetics), hair loss, fatigue, mouth sores, decreased white blood cell count (neutropenia), decreased platelet count (thrombocytopenia), and nerve tingling in the hands and feet (peripheral neuropathy). At GHC Hospitals, our chemotherapy team provides detailed pre-treatment counselling so patients know what to expect, and we monitor blood counts and organ function throughout the treatment course to manage side effects proactively.
What is immunotherapy and who is eligible for it?
Immunotherapy uses checkpoint inhibitor drugs to help the immune system recognise and attack cancer cells. Not every patient is eligible. Eligibility depends on PD-L1 expression in the tumour, tumour mutational burden (TMB), MSI status, cancer type, and overall health. At GHC Hospitals, our cancer specialist in Mumbai and Thane orders appropriate biomarker testing before recommending immunotherapy, ensuring patients who receive it have a meaningful chance of benefiting from it.
What is targeted therapy and how is it different from chemotherapy?
Targeted therapy uses drugs that specifically attack cancer cells with certain gene mutations or protein abnormalities, while leaving normal cells largely unaffected. Chemotherapy, in contrast, kills all rapidly dividing cells including normal ones, which is why it causes more generalised side effects. Targeted therapy requires molecular testing first to confirm that the patient’s tumour carries the specific target. Examples include EGFR inhibitors for lung cancer, HER2 inhibitors for breast cancer, and BCR-ABL inhibitors for CML. GHC Hospitals uses molecular diagnostics including NGS and IHC to identify targetable mutations before recommending targeted therapy.
Is bone marrow transplant available at GHC Hospitals in Thane?
GHC Hospitals is building its bone marrow transplant in Mumbai and Thane programme to offer autologous and allogeneic transplant services to patients in the Thane and Navi Mumbai area at a reasonable cost. Our haematology and medical oncology team currently manages blood cancer patients through chemotherapy induction and consolidation, and coordinates transplant planning for eligible patients. Please contact us to discuss your specific case and the current status of our BMT programme.
How do I get a second opinion for my cancer diagnosis at GHC Hospitals?
To get a second opinion oncology in Mumbai at GHC Hospitals, bring your original biopsy and histopathology report, all imaging studies with original films or CDs, pathology slides if available, previous treatment records, and your current medication list. Our medical oncologist will review all material at a dedicated consultation and provide a written opinion. Call +91 8104242551 to book a second opinion appointment.
Does GHC Hospitals accept insurance for cancer treatment?
Yes. GHC Hospitals accepts most major private health insurance, government mediclaim, CGHS, and Ayushman Bharat PMJAY for cancer treatment at our Thane oncology centre. Contact our billing and insurance desk to confirm coverage for your specific insurance provider and treatment type before your first visit.
How do I prepare for my first oncology consultation at GHC Hospitals?
For your first appointment at our cancer hospital in Mumbai and Thane, please bring all available medical reports including biopsy or pathology reports, CT, MRI, or PET scan reports with the original films or CDs, blood test reports, any previous treatment records or discharge summaries, a list of all current medications including supplements, and your health insurance card. The more information you bring, the more useful your first consultation will be. Our medical oncologist will take a detailed history, review all reports, and discuss the next steps with you clearly.